0001944048-23-000066.txt : 20230825 0001944048-23-000066.hdr.sgml : 20230825 20230825183820 ACCESSION NUMBER: 0001944048-23-000066 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230823 FILED AS OF DATE: 20230825 DATE AS OF CHANGE: 20230825 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Xie Bing CENTRAL INDEX KEY: 0001967716 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41697 FILM NUMBER: 231209684 MAIL ADDRESS: STREET 1: 199 GRANDVIEW ROAD CITY: SKILLMAN STATE: NJ ZIP: 08558 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kenvue Inc. CENTRAL INDEX KEY: 0001944048 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 881032011 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 199 GRANDVIEW ROAD CITY: SKILLMAN STATE: NJ ZIP: 08558 BUSINESS PHONE: 908-874-1200 MAIL ADDRESS: STREET 1: 199 GRANDVIEW ROAD CITY: SKILLMAN STATE: NJ ZIP: 08558 FORMER COMPANY: FORMER CONFORMED NAME: JNTL, Inc. DATE OF NAME CHANGE: 20220825 4 1 wk-form4_1693003089.xml FORM 4 X0508 4 2023-08-23 0 0001944048 Kenvue Inc. KVUE 0001967716 Xie Bing 199 GRANDVIEW ROAD SKILLMAN NJ 08558 0 1 0 0 Group President APAC 0 Restricted Stock Units 2023-08-23 4 A 0 12386 0 A Common Stock 12386 12386 D Restricted Stock Units 2023-08-23 4 A 0 11520 0 A Common Stock 11520 11520 D Restricted Stock Units 2023-08-23 4 A 0 9016 0 A Common Stock 9016 9016 D Restricted Stock Units 2023-08-23 4 A 0 31885 0 A Common Stock 31885 31885 D Restricted Stock Units 2023-08-23 4 A 0 28803 0 A Common Stock 28803 28803 D Restricted Stock Units 2023-08-23 4 A 0 28781 0 A Common Stock 28781 28781 D Stock Options 21.97 2023-08-23 4 A 0 102484 0 A 2033-02-13 Common Stock 102484 102484 D Stock Options 22.40 2023-08-23 4 A 0 113797 0 A 2032-02-14 Common Stock 113797 113797 D Stock Options 22.23 2023-08-23 4 A 0 98988 0 A 2031-02-08 Common Stock 98988 98988 D Stock Options 20.44 2023-08-23 4 A 0 86594 0 A 2030-02-10 Common Stock 86594 86594 D Stock Options 17.82 2023-08-23 4 A 0 56168 0 A 2029-02-11 Common Stock 56168 56168 D Stock Options 17.49 2023-08-23 4 A 0 42263 0 A 2028-02-12 Common Stock 42263 42263 D Stock Options 15.62 2023-08-23 4 A 0 42552 0 A 2027-02-13 Common Stock 42552 42552 D These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. This award is fully vested. /s/ Alla Berenshteyn, as attorney-in-fact 2023-08-25